How do you determine who to place in surveillance and how many employees are you running through the surveillance labs?
Terri
Kindest regards,
Terri
Terri L. Thrasher RN MSN
Sr. Director HR
Employee Health, Occupational Safety, Environmental Health, Employee Relations, Leave Management HR Compliance/Policy, Workers Compensation, 803-SAFE, Injury
Management, Non CCHMC Badging, Early Education and Childcare Center
3333 Burnet Ave
Cincinnati Ohio 45229 MLC 9006
513-636-6240
From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net]
On Behalf Of Allen-Hardy, Blythe
Sent: Tuesday, August 01, 2017 2:22 PM
To: 'MCOH/EH' <mcoh-eh@mylist.net>
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
Cathy,
At Memorial Hermann we have a surveillance program that I am in the process of updating due to the USP 800 requirements. We have a policy in place in our hospitals
on how the drugs are handled etc and it is fairly comprehensive. The medical surveillance I believe as involved checking a CBC, UA and completing an annual questionnaire. I am developing a medical surveillance guideline that will addl laboratory tests such
as LFT’s, BUN/Cr to the CBC w/diff and UA. Will also add a focused exam component for post exposures.
That may be overkill but I want to make sure we have a comprehensive program. Feel free to contact me for further questions.
Blythe Allen-Hardy, MD, FACOEM
Medical Director, Employee Health
Texas Medical Center
6411 Fannin, JB500
Houston, Texas, 77030
W: 713-704-2792
C: 720-840-9593
F: 713-704-6350
From: MCOH-EH [mailto:mcoh-eh-bounces+blythe.allen-hardy=memorialhermann.org@mylist.net]
On Behalf Of Senior, Cathy (Employee Health)
Sent: Tuesday, August 01, 2017 11:42 AM
To: 'MCOH/EH'
Subject: [EXTERNAL] [MCOH-EH] hazardous drug administration
Does anyone have a
medical surveillance plan for employees who handle hazardous drugs. We are seeing more administration of these hazardous drugs between starting the intravesical therapy and the
biologics that are administered. We follow the ONS guidelines for safe handling of hazardous drugs as outlined in our policy. We already have the appropriate work practice in place including proper use of PPE and education for the staff that handle these drugs.
There has been a concern voiced by one of our educators that institutions such as NIOSH have recommendations for medical surveillance to make it a comprehensive prevention program that we do not have in place. Some of the drugs we administer is Carboplatin,
VP-16, Taxol, Cisplatin, Cytoxan, Erbitux, 5-FU, Abraxane, Gemzar, Herceptin, Parieto and Rituxan to name a few. We also give biologics to out-patients in our short stay unit. Any help would be much appreciated. Thanks
Cathy Senior RN BSN CDE
Employee Health Director
Penn Highlands DuBois
100 Hospital Avenue
P.O. Box 447
DuBois Pa 15801
Phone 814-375-3392
Fax 814-372-2610
This email and any attached files are sensitive in nature and intended solely for the intended recipient(s). If you are not the named recipient you should not read, distribute, copy or alter this email. Any views or opinions expressed in this email are those of the author and do not represent those of Penn Highlands Healthcare or its affiliates.. Warning: Although precautions have been taken to make sure no viruses are present in this email, the company cannot accept responsibility for any loss or damage that arise from the use of this email or attachments.